indazoles has been researched along with Pneumothorax in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, M; Kanno, N; Nakahashi, K; Numahata, K; Shiikawa, M; Shiono, S | 1 |
| Aiba, H; Hayashi, K; Kawaguchi, Y; Kimura, H; Miwa, S; Murakami, H; Nakanishi, R; Okamoto, H; Saito, S; Sakai, T; Tatematsu, T; Yamada, S | 1 |
| Ahmed, T; Balagani, A; Grosu, HB; Muhammad, HA; Ost, DE; Sabath, B; Vakil, E; Vial, MR | 1 |
| Ae, K; Gokita, T; Inagaki, L; Matsumoto, S; Motoi, N; Nakano, K; Shimoji, T; Takahashi, S; Tanizawa, T; Tomomatsu, J | 1 |
| Araki, N; Boku, S; Goto, T; Hiraga, H; Honoki, K; Kawai, A; Matsumine, A; Nakamura, T; Nishida, Y; Sudo, A; Sugiura, H; Ueda, T; Yasuda, T; Yonemoto, T | 1 |
| Agrafiotis, AC; Grosdidier, G; Prieto, M; Rios, M; Siat, J; Verhaeghe, JL | 1 |
1 trial(s) available for indazoles and Pneumothorax
| Article | Year |
|---|---|
Pazopanib and soft-tissue sarcomas. Too toxic.
Topics: Angiogenesis Inhibitors; Double-Blind Method; Heart Failure; Humans; Indazoles; Liver; Pneumothorax; Protein Kinase Inhibitors; Pyrimidines; Quality of Life; Sarcoma; Sulfonamides | 2013 |
6 other study(ies) available for indazoles and Pneumothorax
| Article | Year |
|---|---|
[Pneumothorax during Pazopanib Therapy in a Patient with Soft Tissue Sarcoma].
Topics: Aged; Humans; Indazoles; Kidney Neoplasms; Male; Pneumothorax; Pyrimidines; Sarcoma; Sulfonamides | 2021 |
Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Incidence; Indazoles; Lung; Lung Neoplasms; Male; Middle Aged; Pleura; Pneumothorax; Pyrimidines; Retrospective Studies; Risk Assessment; Risk Factors; Soft Tissue Neoplasms; Sulfonamides; Time Factors | 2021 |
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study.
Topics: Adult; Aged; Case-Control Studies; Female; Humans; Indazoles; Logistic Models; Lung Neoplasms; Male; Middle Aged; Pneumothorax; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Risk Factors; Sarcoma; Sulfonamides | 2018 |
Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.
Topics: Adult; Angiogenesis Inhibitors; Humans; Incidence; Indazoles; Male; Middle Aged; Pneumothorax; Pyrimidines; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2014 |
The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Chemical and Drug Induced Liver Injury; Disease-Free Survival; Female; Fibrosarcoma; Humans; Hypertension; Indazoles; Japan; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neurilemmoma; Pneumothorax; Product Surveillance, Postmarketing; Pyrimidines; Retrospective Studies; Sarcoma; Sarcoma, Synovial; Sulfonamides; Survival Analysis; Thrombocytopenia | 2016 |
[Treatment of bilateral spontaneous pneumothorax during pazopanib therapy for pulmonary soft tissue sarcoma metastases. What to do when there is so few evidence?]
Topics: Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Pneumonectomy; Pneumothorax; Pyrimidines; Sarcoma; Sulfonamides | 2016 |